Clostridioides difficile Prevalence in the United States: National Inpatient Sample, 2016 to 2018-Reference-Cited by-同舟云学术

Clostridioides difficile Prevalence in the United States: National Inpatient Sample, 2016 to 2018

Published:2021-07-30 Issue:9 Volume:8 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Petersen Molly R¹,Cosgrove Sara E²,Klein Eili Y³,Zhu Xianming¹,Quinn Thomas C²⁴,Patel Eshan U¹⁵,Grabowski M Kate¹⁵,Tobian Aaron A R¹²⁵

Affiliation:

1. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

2. Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

3. Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

4. Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA

5. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA

Abstract

Abstract Data from the National Inpatient Sample indicate that Clostridioides difficile prevalence decreased from 10.1 (95% confidence interval [CI] = 9.9–10.3) to 8.6 (95% CI = 8.5–8.8) per 1000 hospital discharges between 2016 and 2018, after accounting for age, sex, and race. There was heterogeneity in the prevalence and decrease in prevalence by geographic region in the United States.

Funder

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Centers for Disease Control and Prevention

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

http://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofab409/39459234/ofab409.pdf

Reference12 articles.

1. Clostridium difficile infection;Leffler;N Engl J Med,2015

2. Mortality, hospital costs, payments, and readmissions associated with Clostridium difficile infection among medicare beneficiaries;Drozd;Infect Dis Clin Pract (Baltim Md),2015

3. Burden of Clostridium difficile infection in the United States;Lessa;N Engl J Med,2015

4. Trends in U.S. burden of Clostridioides difficile infection and outcomes;Guh;N Engl J Med,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comparison of the Efficacy of Treatment With Fidaxomicin Versus Vancomycin in Clostridioides difficile Infection;Cureus;2023-11-13

2. Frequency and Impact of Infectious Disease Conditions Diagnosed During Decompensated Heart Failure Hospitalizations in the United States;The American Journal of Cardiology;2023-03

3. Increasing Trends of Clostridium difficile Infection in Hospitalized Young Patients: A Study of the National Inpatient Sample From 2007 to 2017;Cureus;2022-09-23